✦ LIBER ✦

Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients

✍ Scribed by de Wit, R; Kruit, WHJ; Stoter, G; de Boer, M; Kerger, J; Verweij, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interim results of a phase II study of d

✍ Mattson, K.; Le Chevalier, T.; Bospuée, L.; Pujol, J.L.; Culine, S.; Dabouis, G. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 270 KB

A phase II trial of docetaxel (Taxotere®

✍ Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

A phase II study of weekly docetaxel in

✍ Hugo E. R. Ford; Yoon-Sim Yap; David W. Miles; Andreas Makris; Marcia Hall; Liz 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 311 KB

A phase II study of capecitabine plus do

✍ Soares, Heloisa P.; Bayraktar, Soley; Blaya, Marcelo; Lopes, Gilberto; Merchan, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 287 KB

Phase II study of docetaxel plus enoxapa

✍ Robert, Francisco; Busby, Elizabeth; Marques, Marisa B; Reynolds, Robert E; Care 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Phase II Study of Trastuzumab plus Gemci

✍ Joyce A. O'Shaughnessy; Sasha Vukelja; Thomas Marsland; Gary Kimmel; Suresh Ratn 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB